Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2684 |
|
Actual shortage: | 240 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2435 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
24 (10%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-BUDESONIDE | 0.5MG | SUSPENSION | Resolved | 2021-04-29 | 2021-08-07 | 138291 |
TEVA-BUDESONIDE | 0.125MG | SUSPENSION | Resolved | 2021-06-03 | 2021-10-14 | 140390 |
TEVA-BUDESONIDE | 0.5MG | SUSPENSION | Resolved | 2021-12-17 | 2022-02-05 | 151448 |
TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Resolved | 2022-01-20 | 2022-03-24 | 153141 |
TEVA-PREDNISOLONE | 1% | SUSPENSION | Resolved | 2022-03-31 | 2022-06-17 | 157647 |
TEVA-PREDNISOLONE | 1% | SUSPENSION | Resolved | 2022-04-28 | 2022-05-26 | 159581 |
TEVA-BUDESONIDE | 0.5MG | SUSPENSION | Resolved | 2022-05-19 | 2022-06-09 | 160994 |
TEVA-BUDESONIDE | 0.5MG | SUSPENSION | Resolved | 2022-08-18 | 2023-07-05 | 167156 |
TEVA-BUDESONIDE | 0.125MG | SUSPENSION | Resolved | 2022-08-18 | 2023-10-06 | 167197 |
TEVA-PREDNISOLONE | 1% | SUSPENSION | Resolved | 2022-08-18 | 2022-10-01 | 167206 |
TEVA-PREDNISOLONE | 1% | SUSPENSION | Resolved | 2022-10-17 | 2023-06-09 | 172030 |
TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Resolved | 2022-10-28 | 2022-12-15 | 173052 |
TEVA-PREDNISOLONE | 1% | SUSPENSION | Resolved | 2022-12-15 | 2023-06-09 | 178527 |
TEVA-BUDESONIDE | 0.5MG | SUSPENSION | Actual shortage | 2023-06-19 | 2024-05-16 | 195478 |
TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Resolved | 2023-06-19 | 2023-07-14 | 195501 |
TEVA-BUDESONIDE | 0.125MG | SUSPENSION | Resolved | 2023-06-20 | 2023-07-06 | 195815 |
TEVA-PREDNISOLONE | 1% | SUSPENSION | Resolved | 2023-06-20 | 2023-06-27 | 195861 |
TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Resolved | 2023-07-27 | 2023-08-04 | 200231 |
TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Resolved | 2023-08-17 | 2023-12-14 | 202239 |
TEVA-BUDESONIDE | 0.125MG | SUSPENSION | Resolved | 2023-11-03 | 2024-01-19 | 209145 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64626 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-19 | 2018-10-19 | 64852 | ||
ACT CLOPIDOGREL | Discontinued | 2018-10-19 | 2018-10-19 | 65065 | ||
ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65284 | ||
ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65289 | ||
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81330 | ||
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81337 | ||
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81344 | ||
HYDROCORTISONE SODIUM SUCCINATE INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81347 | ||
TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106136 | ||
TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106139 | ||
RATIO-SALBUTAMOL | Discontinued | 2020-02-13 | 2020-02-13 | 106151 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106155 | ||
EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106170 | ||
LINEZOLID INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106173 | ||
EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106176 | ||
NOVAMOXIN | 500MG | CAPSULE | Discontinued | 2017-06-27 | 2017-06-27 | 14046 |
RATIO-FENOFIBRATE MC | 200MG | CAPSULE | Discontinued | 2018-10-12 | 2018-10-12 | 63943 |
RATIO-FENOFIBRATE MC | 200MG | CAPSULE | Discontinued | 2018-10-19 | 2018-10-19 | 64891 |
TEVA-TECNAL C 1/4 | 330MG 50MG 15MG 40MG | CAPSULE | Discontinued | 2019-04-11 | 2019-04-11 | 81353 |